Upstream Bio (UPB) Equity Ratio (2023 - 2025)
Upstream Bio has reported Equity Ratio over the past 3 years, most recently at 0.96 for Q4 2025.
- Quarterly results put Equity Ratio at 0.96 for Q4 2025, down 1.53% from a year ago — trailing twelve months through Dec 2025 was 0.96 (down 1.53% YoY), and the annual figure for FY2025 was 0.96, down 1.53%.
- Equity Ratio for Q4 2025 was 0.96 at Upstream Bio, down from 0.97 in the prior quarter.
- Over the last five years, Equity Ratio for UPB hit a ceiling of 0.98 in Q1 2025 and a floor of 1.05 in Q4 2023.
- Median Equity Ratio over the past 3 years was 0.97 (2025), compared with a mean of 0.44.
- Peak annual rise in Equity Ratio hit 240.48% in 2025, while the deepest fall reached 1.53% in 2025.
- Upstream Bio's Equity Ratio stood at 1.05 in 2023, then soared by 192.84% to 0.98 in 2024, then fell by 1.53% to 0.96 in 2025.
- The last three reported values for Equity Ratio were 0.96 (Q4 2025), 0.97 (Q3 2025), and 0.97 (Q2 2025) per Business Quant data.